Library — CHDR

Search

Filter

Profiling the subjective effects of Δ⁹-tetrahydrocannabinol using visual analogue scales.

Kleinloog D, Roozen F, De Winter W, Freijer J, Van Gerven J

International journal of methods in psychiatric research, 2014 May; 23(2):245-56

View publication
Spatial heterogeneity of the relation between resting-state connectivity and blood flow: an important consideration for pharmacological studies.

Khalili-Mahani N, van Osch MJ, de Rooij M, Beckmann CF, van Buchem MA, Dahan A, van Gerven JM, Rombouts SA

Human brain mapping, 2014 Feb; 35(3):929-42

View publication
Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

Klumpers LE, Fridberg M, de Kam ML, Little PB, Jensen NO, Kleinloog HD, Elling CE, van Gerven JM

British journal of clinical pharmacology, 2013 Nov; 76(6):846-57

View publication
Differential and distributed effects of dopamine neuromodulations on resting-state network connectivity.

Cole DM, Beckmann CF, Oei NY, Both S, van Gerven JM, Rombouts SA

NeuroImage, 2013 Aug

View publication
Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady state.

te Beek ET, Tatosian D, Majumdar A, Selverian D, Klaassen ES, Petty KJ, Gargano C, van Dyck K, McCrea J, Murphy G, van Gerven JM

Journal of clinical pharmacology, 2013 Jul; 53(8):846-56

View publication
Dopamine-dependent architecture of cortico-subcortical network connectivity.

Cole DM, Oei NY, Soeter RP, Both S, van Gerven JM, Rombouts SA, Beckmann CF

Cerebral cortex (New York, N.Y. : 1991), 2013 Jun; 23(7):1509-16

View publication
Tolerability, pharmacokinetics, and pharmacodynamics of single-dose almorexant, an orexin receptor antagonist, in healthy elderly subjects.

Hoever P, Hay J, Rad M, Cavallaro M, van Gerven JM, Dingemanse J

Journal of clinical psychopharmacology, 2013 May; 33(3):363-70

View publication
Pharmacokinetics and central nervous system effects of the novel dual NK1 /NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers.

te Beek ET, Hay JL, Bullman JN, Burgess C, Nahon KJ, Klaassen ES, Gray FA, van Gerven JM

British journal of clinical pharmacology, 2013 Apr; 75(5):1328-39

View publication
Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.

Kuepper R, Ceccarini J, Lataster J, van Os J, van Kroonenburgh M, van Gerven JM, Marcelis M, Van Laere K, Henquet C

PloS one, 2013 Apr; 8(7):e70378

View publication

«
1
2
...
7
8
9
10
11
12
13
...
18
19
»